Table 4.

Mean (95% CI) change from baseline in mLNSC and mUFC at month 12.

	mLNSC (nmol/L)		mUFC (nmol/24 h)
	n	Change from baseline at month 12	n	Change from baseline at month 12
All	86	−3.3 (−5.6, −1.0)	104	−222.4 (−288.5, −156.2)
mUFC control at month 12
Controlled	37	−6.9 (−11.4, −2.4)	45	−326.9 (−430.8, −223.1)
Partially controlled	18	0.8 (−3.1, 4.6)	21	−440.9 (−532.9, −348.9)
Uncontrolled	31	−1.3 (−3.7, 1.2)	38	22.3 (−55.7, 100.2)
mLNSC control at month 12*
Controlled	19	−9.0 (−16.5, −1.4)	21	−330.2 (−557.7, −102.7)
Uncontrolled	67	−1.7 (−3.7, 0.4)	71	−213.8 (−273.5, −154.2)
Diabetic status at baseline
Diabetic	33	−3.5 (−8.1, 1.1)	41	−235.7 (−337.2, −134.3)
Pre-diabetic	13	−2.6 (−6.9, 1.7)	17	−120.0 (−298.1, 58.0)
Non-diabetic	40	−3.3 (−6.5, −0.1)	46	−248.2 (−353.5, −143.0)
Hypertension status at baseline
Hypertensive	62	−3.0 (−5.9, −0.2)	75	−185.4 (−256.2, −114.6)
Pre-hypertensive	15	−2.7 (−4.6, −0.8)	18	−308.4 (−492.2, −124.6)
Normotensive	9	−5.8 (−17.8, 6.2)	11	−333.6 (−649.7, −17.6)
Age
<60 years	80	−2.5 (−4.5, −0.4)	97	−218.4 (−283.1, −153.6)
≥60 years	6	−14.0 (−36.4, 8.4)	7	−277.4 (−809.5, 254.6)
Sex
Male	22	−1.7 (−5.2, 1.9)	24	−150.4 (−242.4, −58.4)
Female	64	−3.8 (−6.7, −0.9)	80	−243.9 (−325.7, −162.2)

*92 of the 104 patients who had mUFC assessments at baseline and month 12 (for calculation of mean change) also had mLNSC assessments at each of these time points.